Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CALL
Toronto Dominion Bank
TD
$193B
| $243K | 0.01% |
+3,700
| New | +$269K |
|
1702
Teekay
TK
$1.17B
| $243K | 0.01% |
+84,407
| New | +$276K |
|
1703
Valmont Industries
VMI
$9.29B
| $243K | 0.01% |
+1,083
| New | +$265K |
|
1704
CALL
Yeti Holdings
YETI
$3.14B
| $243K | 0.01% |
5,600
+1,500
| +37% | +$72.9K |
|
1705
CALL
Airbnb
ABNB
$112B
| $242K | 0.01% |
+2,700
| New | +$351K |
|
1706
Celularity
CELU
$22.4M
| $241K | 0.01% |
+7,079
| New | +$575K |
|
1707
CALL
Enbridge
ENB
$109B
| $241K | 0.01% |
5,700
-3,700
| -39% | -$165K |
|
|
SNCR
1708
DELISTED
Synchronoss Technologies
SNCR
| $241K | 0.01% |
23,333
| – | – |
|
|
BFS
1709
Saul Centers
BFS
$844M
| $240K | 0.01% |
+5,100
| New | +$251K |
|
1710
Cass Information Systems
CASS
$735M
| $240K | 0.01% |
7,088
-8,441
| -54% | -$303K |
|
1711
CALL
GitLab
GTLB
$7.1B
| $240K | 0.01% |
+4,500
| New | +$209K |
|
1712
PUT
Lennar Class A
LEN
$21.2B
| $240K | 0.01% |
+3,512
| New | +$257K |
|
1713
PUT
Eaton
ETN
$159B
| $239K | 0.01% |
+1,900
| New | +$266K |
|
1714
Treace Medical Concepts
TMCI
$284M
| $239K | 0.01% |
+16,634
| New | +$280K |
|
|
RPT
1715
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $239K | 0.01% |
+24,319
| New | +$295K |
|
1716
PUT
Synchrony
SYF
$26B
| $238K | 0.01% |
+8,600
| New | +$299K |
|
|
VSTO
1717
PUT
DELISTED
Vista Outdoor Inc.
VSTO
| $237K | 0.01% |
+8,500
| New | +$303K |
|
1718
PUT
LyondellBasell Industries
LYB
$21.1B
| $236K | 0.01% |
2,700
-900
| -25% | -$93.8K |
|
1719
CALL
Virtu Financial
VIRT
$5.85B
| $236K | 0.01% |
+10,100
| New | +$289K |
|
1720
PUT
Fluor
FLR
$6.86B
| $235K | 0.01% |
+9,700
| New | +$261K |
|
1721
Adient
ADNT
$1.46B
| $234K | 0.01% |
+7,893
| New | +$265K |
|
1722
PUT
Alpha Metallurgical Resources
AMR
$2.66B
| $234K | 0.01% |
+1,800
| New | +$272K |
|
|
LTHM
1723
PUT
DELISTED
Livent Corporation
LTHM
| $234K | 0.01% |
+10,300
| New | +$265K |
|
1724
PUT
Exelon
EXC
$45.7B
| $233K | 0.01% |
5,100
-2,600
| -34% | -$122K |
|
1725
PUT
SM Energy
SM
$8.67B
| $232K | 0.01% |
+6,800
| New | +$276K |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.